Goldman Sachs Group Inc Wave Life Sciences Ltd. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 537,020 shares of WVE stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
537,020
Previous 374,363
43.45%
Holding current value
$5.36 Million
Previous $3.07 Million
116.42%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$182 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$96.1 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$82.5 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$67.3 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$67.1 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $867M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...